How We Work / User eXperience

Sensory alterations in patients with cancer

Taste and smell are essential senses that work together, allowing us to perceive flavour.1Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984 The sense of taste helps to regulate food intake by allowing us to decide quickly whether to accept or reject a food.2Murtaza B, Hichami A, Khan AS, et al. Front Physiol. Published on 2017;8:134 Taste perception activates neuronal pathways, aiding the digestion, absorption and storage of nutrients.3Murtaza B, Hichami A, Khan AS, et al. Front Physiol. Published on 2017;8:134 Taste also provides hedonic pleasure from eating.4Murtaza B, Hichami A, Khan AS, et al. Front Physiol. Published on 2017;8:134

Disturbances in taste perception, known as dysgeusia, can occur for many different reasons, including disease and medication.5Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984 Altered taste perception is especially important in cancer as it can lead to reduced food intake, weight loss, and malnutrition  – all of which are linked to poor disease outcomes and lower quality of life.6Arends J, Bachmann P, Baracos V, et al. Clin Nutr. Published on 2017;36(1):11-48

How common are sensory changes in cancer?

Taste changes affect up to 70% of patients with cancer.7Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984   This compares with a reported prevalence of 20% in the general population.8Vennemann MM, Hummel T, Berger K, J Neurol. Published on 2008; 255(8): 1121–1126 Taste changes have been reported before, during, and after treatment for cancer; in many different tumour types; and in patients receiving either chemotherapy or radiotherapy.9Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984  

Despite their near-ubiquity, taste changes in cancer patients are not always recognised by clinicians and researchers, leaving important questions unanswered.10Murtaza B, Hichami A, Khan AS, et al. Front Physiol. Published on 2017;8:134 For instance, the physiological mechanisms underlying taste alterations have not been fully elucidated and there is no “gold standard” assessment tool.11Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984

What type of sensory changes occur in cancer?

Sensory changes in patients with cancer occur as a consequence of the disease or its treatment. They manifest in various ways:12Brisbois TD, de Kock IH, Watanabe SM del. et al. J Pain Symptom Manage. Published on 2011;41(4):673-83 /

  • Taste aversion to some flavours
  • Changes in mouth feeling
  • Changes in flavour thresholds
  • Changes in flavour preference
  • Bad tastes in the mouth
  • Variation in smell

Disturbances of all taste modalities have been reported in cancer patients. Hyper- and hypogeusia for salt and sweet tastes are widespread, while changes to bitter and sour have been reported.13Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984

Metallic taste is also common; in a recent study, 16% of cancer patients receiving chemotherapy, radiotherapy, or targeted therapy reported a metallic taste. These individuals also tended to experience hypergeusia for sour and bitter tastes.14IJpma I, Timmermans ER, Renken RJ, et al. Nutr Cancer. Published on 2017;69(1):140-145 / In another study, breast cancer patients undergoing chemotherapy showed an altered preference for certain macronutrients rather than specific tastes.15de Vries YC, Winkels RM, van den Berg MMGA, et al. Food Qual Prefer. Published on 2018; 63: 135–143

Taste and smell alterations are typically noticed by patients shortly after treatment begins and may persist for 6–12 months after treatment ends.16Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984 Occasionally, cancer-associated dysgeusia is permanent.17Ruo Redda MG and Allis S, Cancer Treat Rev. Published on 2006;32:541–547

View References

View References
1, 5, 7, 9, 11, 13, 16 Spotten LE, Corish CA, Lorton CM, et al. Ann Oncol. Published on 2017;28(5):969-984
2, 3, 4, 10 Murtaza B, Hichami A, Khan AS, et al. Front Physiol. Published on 2017;8:134
6 Arends J, Bachmann P, Baracos V, et al. Clin Nutr. Published on 2017;36(1):11-48
8 Vennemann MM, Hummel T, Berger K, J Neurol. Published on 2008; 255(8): 1121–1126
12 Brisbois TD, de Kock IH, Watanabe SM del. et al. J Pain Symptom Manage. Published on 2011;41(4):673-83 /
14 IJpma I, Timmermans ER, Renken RJ, et al. Nutr Cancer. Published on 2017;69(1):140-145 /
15 de Vries YC, Winkels RM, van den Berg MMGA, et al. Food Qual Prefer. Published on 2018; 63: 135–143
17 Ruo Redda MG and Allis S, Cancer Treat Rev. Published on 2006;32:541–547